The closure of Sugen.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 969, doi. 10.1038/nbt0903-969a
- By:
- Publication type:
- Article
Works matching DE "SUGEN Inc."
Results: 6
1
2
Sugen falls as casualty of Pfizer-Pharmacia merger.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 7, p. 722, doi. 10.1038/nbt0703-722
- By:
- Publication type:
- Article
3
Sugen's strategy: a signal for P&U purchase.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 8, p. 745, doi. 10.1038/11670
- By:
- Publication type:
- Article
4
Sugen's European strategy.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 6, p. 521, doi. 10.1038/9793
- By:
- Publication type:
- Article
5
Research retreat: Pfizer eliminates Sugen, shrinks cancer infrastructure.
- Published in:
- 2003
- By:
- Publication type:
- journal article
6
Tyrosine kinase inhibitor research presses on despite halted clinical trial.
- Published in:
- 2000
- By:
- Publication type:
- journal article